Status:

RECRUITING

Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome

Lead Sponsor:

The Canadian College of Naturopathic Medicine

Collaborating Sponsors:

Sunnybrook Health Sciences Centre

Lotte & John Hecht Memorial Foundation

Conditions:

Perinatal Depression

PerinatalAnxiety

Eligibility:

FEMALE

18-43 years

Phase:

PHASE2

PHASE3

Brief Summary

Perinatal depression and anxiety (PDA) are the leading causes of maternal mortality in developed countries. Women with a history of depression have a 20 fold higher risk of PDA at subsequent pregnanci...

Detailed Description

Pregnant women with a history of anxiety and/or depression \& currently stable, will be recruited and randomized or assigned to one of four study groups. A total of 100 will be recruited and required ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Women 18-43 years old
  • 12-35 weeks of gestation
  • Non-smoker/alcohol/recreational drug user
  • Financially stable
  • Clinical diagnosis of lifetime depression/anxiety or PDA but currently well
  • English speaking
  • Exclusion Criteria:
  • Body Mass Index (BMI)≥30
  • Low income (unable to afford basic daily needs (i.e., shelter, food, etc.)
  • Diagnosis with other major mental health disorders (Bipolar, Psychosis, Addiction, Schizophrenia);
  • Diagnosis with other severe medical conditions (i.e. epilepsy, neurological disorders, etc.)
  • Allergies to fish oils/ingredients in supplements
  • Conditions that require repeated/chronic antibiotic usage
  • Having a child with significant mental/physical disability
  • Single mothers without any kind of family support,
  • Cigarette, alcohol and recreational drug users
  • Women unwilling to switch to study product(s)
  • Multiparous women with young children (i.e. one or more children less than 4 years of age at the time of delivery)
  • Non-English Readers/Speakers

Exclusion

    Key Trial Info

    Start Date :

    August 15 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 1 2028

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT06074250

    Start Date

    August 15 2024

    End Date

    March 1 2028

    Last Update

    August 27 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Sunnybrook Health Science Center

    Toronto, Ontario, Canada, M4N 3M5